{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:36:54Z","timestamp":1793162214569,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtct.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:23:49Z","timestamp":1776576229000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["QTc Prolongation in Allogeneic Hematopoietic Stem Cell Transplantation: Assessing Cardiac Complications and Survival Outcomes"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6293-7758","authenticated-orcid":false,"given":"Mark F.","family":"deBettencourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7964-1390","authenticated-orcid":false,"given":"Kayeromi","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M.","family":"Carrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri J.","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1856-4292","authenticated-orcid":false,"given":"Alexander S.","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryann C.","family":"Aririguzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yustina M.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Nallani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8265-9340","authenticated-orcid":false,"given":"Patrick J.","family":"Stiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.04.011_bib0001","series-title":"StatPearls","article-title":"Electrocardiogram","author":"Sattar","year":"2023"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.011_bib0002","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1573403X10666140514103612","article-title":"The measurement of the QT interval","volume":"10","author":"Postema","year":"2014","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.jtct.2026.04.011_bib0003","first-page":"353","volume":"7","author":"Bazett","year":"1920"},{"key":"10.1016\/j.jtct.2026.04.011_bib0004","series-title":"StatPearls","article-title":"Long QT syndrome","author":"Al-Akchar","year":"2023"},{"issue":"21","key":"10.1016\/j.jtct.2026.04.011_bib0005","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","article-title":"Female gender as a risk factor for Torsades de Pointes associated with cardiovascular drugs","volume":"270","author":"Makkar","year":"1993","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.jtct.2026.04.011_bib0006","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/CIRCULATIONAHA.109.192704","article-title":"Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation","volume":"121","author":"Drew","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.011_bib0007","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0735-1097(99)00226-0","article-title":"Exaggerated QT prolongation after cardioversion of atrial fibrillation","volume":"34","author":"Choy","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.jtct.2026.04.011_bib0008","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/2042098612454283","article-title":"Drug-induced QT interval prolongation: mechanisms and clinical management","volume":"3","author":"Nachimuthu","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jtct.2026.04.011_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.966331","article-title":"Drug-induced Torsades de Pointes: disproportionality analysis of the United States Food and Drug Administration adverse event reporting system","volume":"9","author":"Wu","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.011_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000986","article-title":"Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association","volume":"144","author":"Fradley","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.011_bib0011","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.011_bib0012","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtct.2026.04.011_bib0013","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/bmt.2009.216","article-title":"The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation","volume":"45","author":"Guthrie","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"20","key":"10.1016\/j.jtct.2026.04.011_bib0014","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.jacc.2017.09.1095","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2","volume":"70","author":"Chang","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.011_bib0015","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/AAC.00958-12","article-title":"Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients","volume":"57","author":"Zeuli","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jtct.2026.04.011_bib0016","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/bcp.13457","article-title":"QTc prolongation during ciprofloxacin and fluconazole combination therapy: prevalence and associated risk factors","volume":"84","author":"Berger","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"19","key":"10.1016\/j.jtct.2026.04.011_bib0017","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1161\/CIR.0000000000000527","article-title":"Update to practice standards for electrocardiographic monitoring in hospital settings: a scientific statement from the American Heart Association","volume":"136","author":"Sandau","year":"2017","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.jtct.2026.04.011_bib0018","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/bmt.2015.64","article-title":"Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995 consecutive patients at a single center","volume":"50","author":"Miller","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.04.011_bib0019","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/10781552221074016","article-title":"QTc prolongation during levofloxacin and triazole combination chemoprophylaxis: prevalence and predisposing risk factors in a cohort of hematopoietic cell transplantation recipients","volume":"29","author":"Moghnieh","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jtct.2026.04.011_bib0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jcrc.2019.09.014","article-title":"The incidence, predictors and outcomes of QTc prolongation in critically ill patients","volume":"54","author":"Russell","year":"2019","journal-title":"J Crit Care"},{"key":"10.1016\/j.jtct.2026.04.011_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.894623","article-title":"Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer","volume":"9","author":"Rowe","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.jtct.2026.04.011_bib0022","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1001\/jamaoncol.2022.4194","article-title":"Association of QTc formula with the clinical management of patients with cancer","volume":"8","author":"Richardson","year":"2022","journal-title":"JAMA Oncol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726002721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726002721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:16:12Z","timestamp":1793160972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726002721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":22,"alternative-id":["S2666636726002721"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.011","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QTc Prolongation in Allogeneic Hematopoietic Stem Cell Transplantation: Assessing Cardiac Complications and Survival Outcomes","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}